AN EIGHT-WEEK RANDOMIZED,DOUBLE-BLIND STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FIXED-DOSE COMBINATIONS OF T80+A5 VERSUS A5 MONOTHERAPY IN PATIENTS WITH HYPERTENSION WHO FAIL TO RESPOND ADEQUATELY TO TREATMENT WITH A5 MONOTHERAPY: